radioterapin

Radioterapin, also known as radiation therapy, is a medical treatment where ionizing radiation is used to destroy or damage cancer cells, thereby preventing their growth and division. This form of therapy can be administered through various methods, including external beam radiation therapy (EBRT), internal radiation therapy (brachytherapy), and systemic radiation therapy (radiopharmaceuticals).

External beam radiation therapy involves directing high-energy beams at the tumor site from outside the body. This technique is commonly used to treat tumors on the skin or deeper in the body, such as the brain, spine, or lungs. The treatment is often given in repeated sessions, with the dose and frequency adjusted according to the patient's specific needs.

Internal radiation therapy, also known as brachytherapy, involves placing a radioactive material directly into or near the tumor site. This method is often used to treat tumors in the chest, pelvis, or prostate gland. The radioactive material can be placed in small containers or seeds, which are left in place for a few minutes to a few hours before being removed.

Systemic radiation therapy involves administering radioactive isotopes orally, intravenously, or through injections. This approach is typically used to treat tumors that have spread to multiple parts of the body. The radioactive isotopes can target cancer cells throughout the body, reducing the cancer's growth and its ability to spread further.

Radioterapin can be used alone or in combination with other cancer treatments, such as chemotherapy and surgery. It is an important tool in the fight against cancer, as it can help reduce the incidence of recurrence and improve the quality of life for patients undergoing cancer treatment.